Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection

被引:66
作者
Kaufmann, GR
Cunningham, P
Kelleher, AD
Zaunders, J
Carr, A
Vizzard, J
Law, M
Cooper, DA
机构
[1] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia
[2] St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia
[3] St Vincents Hosp, HIV Med Unit, Sydney, NSW 2010, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1086/314480
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study used curve-fitting techniques to detail the dynamics of human immunodeficiency virus (HIV)-1 and its relationship to circulating T lymphocyte changes in a cohort of 41 male patients (mean age 36 +/- 7 years) infected with HIV-1, The following characteristics of viral kinetics were obtained: virus load peak, 6.35 +/- 0.71 log(10) RNA copies/mL at 12.2 +/- 7.1 days; virus load drop from peak, 2.02 +/- 0.93 log(10) copies/mL; viral decay rate from peak, 0.071 +/- 0.042 log(10) RNA copies/mL/day; and steady state virus load, 4.57 +/- 0.68 log(10) copies/ mL at 135 +/- 81 days. Analysis of individual virus load curves revealed highly variable viral kinetics, Although these could be grouped into three distinct patterns, virus load and CD4 lymphocyte counts were similar in all patterns at 12 months, but the interval from infection to achievement of steady state virus load varied significantly.
引用
收藏
页码:1812 / 1815
页数:4
相关论文
共 15 条
[1]   Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [J].
Borrow, P ;
Lewicki, H ;
Wei, XP ;
Horwitz, MS ;
Peffer, N ;
Meyers, H ;
Nelson, JA ;
Gairin, JE ;
Hahn, BH ;
Oldstone, MBA ;
Shaw, GM .
NATURE MEDICINE, 1997, 3 (02) :205-211
[2]  
*CDC, 1992, MMWR-MORBID MORTAL W, V1, P1
[3]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964
[4]  
Gibaldi M., 1982, DRUGS PHARM SCI, V45-109
[5]   KINETICS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) DNA AND RNA-SYNTHESIS DURING PRIMARY HIV-1 INFECTION [J].
GRAZIOSI, C ;
PANTALEO, G ;
BUTINI, L ;
DEMAREST, JF ;
SAAG, MS ;
SHAW, GM ;
FAUCI, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6405-6409
[6]  
LOES SK, 1995, NEW ENGL J MED, V333, P408
[7]   QUANTITATION OF HIV-1 RNA IN PLASMA PREDICTS OUTCOME AFTER SEROCONVERSION [J].
MELLORS, JW ;
KINGSLEY, LA ;
RINALDO, CR ;
TODD, JA ;
HOO, BS ;
KOKKA, RP ;
GUPTA, P .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (08) :573-579
[8]   Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection [J].
Nowak, MA ;
Lloyd, AL ;
Vasquez, GM ;
Wiltrout, TA ;
Wahl, LM ;
Bischofberger, N ;
Williams, J ;
Kinter, A ;
Fauci, AS ;
Hirsch, VM ;
Lifson, JD .
JOURNAL OF VIROLOGY, 1997, 71 (10) :7518-7525
[9]   ANTIGENIC OSCILLATIONS AND SHIFTING IMMUNODOMINANCE IN HIV-1 INFECTIONS [J].
NOWAK, MA ;
MAY, RM ;
PHILLIPS, RE ;
ROWLANDJONES, S ;
LALLOO, DG ;
MCADAM, S ;
KLENERMAN, P ;
KOPPE, B ;
SIGMUND, K ;
BANGHAM, CRM ;
MCMICHAEL, AJ .
NATURE, 1995, 375 (6532) :606-611
[10]   Population dynamics of immune responses to persistent viruses [J].
Nowak, MA ;
Bangham, CRM .
SCIENCE, 1996, 272 (5258) :74-79